Cellect Biotechnology Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed on May 24, 2018, by Cellect Biotechnology Ltd., a foreign private issuer headquartered in Kfar Saba, Israel. The filing serves as a notice regarding the Company's upcoming Annual General Meeting of Shareholders scheduled for June 28, 2018.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice and does not contain financial statements or performance data.
Material Changes
No material financial changes or operational updates versus prior periods are disclosed in this filing. The document focuses solely on the logistics of the shareholder meeting.
Guidance, Outlook, and Management Commentary
Management has announced the Annual General Meeting will be held at the offices of Doron, Tikotzky, Kantor, Gutman & Amit Gross in Bnei Brak, Israel, at 11:00 a.m. Israel time. The filing includes the Notice and Proxy Statement, a Proxy Card for ordinary share holders, and a Voting Instruction Card for ADS holders. No specific business outlook, risk factors, or unusual items are detailed in this text.
Key Facts for Investor Verification
- Annual General Meeting date: June 28, 2018.
- Meeting location: B.S.R 4 Tower, 33rd Floor, 7 Metsada Street, Bnei Brak, Israel.
- Voting materials (Exhibits 99.1, 99.2, and 99.3) are attached to the filing for shareholder action.
- The filing incorporates by reference into Registration Statements on Form S-8 and Form F-3.